Adebrelimab Combined With Chemotherapy for the Esophageal Squamous Cell Carcinoma
Adebrelimab Combined With Chemotherapy for the Esophageal Squamous Cell Carcinoma
Recruiting · NCT07430579 · Registry updated 2026-02-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Adebrelimab Combined With Chemotherapy for the Esophageal Squamous Cell Carcinoma | Disease Attributes, Disease Progression, Pathologic Complete Response, Pathologic Processes, Pathological Conditions, Signs and Symptoms | Recruiting | Not applicable | 2026-02-24 | NCT07430579 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| The Second Hospital of Shandong University | 42 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| The Second Qilu Hospital of Shandong University | Jinan | China | 2 |